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The phytochemical investigation of an ethanol extract of Artemisia afra led to the isolation of six known compounds, acacetin
(1),1 2 α,4α-dihydroxybishopsolicepolide (2), scopoletin (3), α-amyrin (4),p h y t o l(5), and a pentacyclic triterpenoid betulinic
acid (6). The compounds were evaluated for antimicrobial activity against Gram positive (Actinomyces naeslundii, Actinomyces
israelii, and Streptococcus mutans), Gram negative bacteria (Prevotella intermedia, Porphyromonas gingivalis and Aggregatibacter
actinomycetemcomitans previously known as Actinobacillus actinomycetemcomitans), and Candida albicans. The crude extract of A.
afra inhibited the growth of all tested microbial species at concentration range of 1.6mg/mL to 25mg/mL. The compounds 1–6
also showed activity range at 1.0mg/mL to 0.25mg/mL. Three best compounds (scopoletin, betulinic acid, and acacetin) which
showed good antimicrobial activity were selected for further studies. Cytotoxicity of extract and compounds was determined
using the XTT cell proliferation kit. The antioxidant activity of the extract and compounds was done using the DPPH scavenging
method.TheextractshowedgoodantioxidantactivitywithanIC50 value of 22.2μg/mL.Scopoletin hada strongtransformationof
the DPPH radical into its reduced form, with an IC50 value of 1.24μg/mL which was signiﬁcant to that of vitamin C (1.22μg/mL).
AcacetinandbetulinicacidexhibitedadecreasedscavengingactivitywiththeIC50 of2.39 and2.42μg/mL,respectively.Theextract
and compounds showed moderate toxicity on McCoy ﬁbroblast cell line and scopoletin was relatively nontoxic with an IC50
value of 132.5μg/mL. Acacetin and betulinic acid also showed a smooth trend of non-toxic eﬀects with IC50 values of 35.44 and
30.96μg/mL. The obtained results in this study conﬁrm the use of A. afra in the treatment of microbial infections.
1.Introduction
Periodontal disease is a chronic, multifactorial disease of the
tissue supporting teeth [1]. It is characterised by local infec-
tion and inﬂammation in teeth supporting tissue leading
t oc o n n e c t i v et i s s u ed e s t r u c t i o na n da l v e o l a rb o n el o s s[ 2].
The etiology of periodontitis is the oral bacteria [3, 4]. If
left untreated, periodontitis can have medical consequences
such as weight loss, chronic pain, sore or loss teeth, swollen
gums, tooth decay, breakage of the maxillary or mandibular
bones, and renal, coronary, and hepatic diseases [5–7].
The population of periodontal bacteria begins to increase
as an anaerobic environment is produced due to oxygen
scavenging activity of the early subgingival colonizers [4].
These bacterial populations lead to bioﬁlm formation which
consists of microcolonies, extracellular layers, ﬂuid channels,
and communication systems [8]. Bioﬁlms may consist of
morethan700diﬀerentmicrobialspecieswhichleavesymbi-
otically and incubate each other [9]. The bioﬁlm formation
and associated disease can be prevented by daily tooth
brushingandchemotherapeuticagentssuchaschlorhexidine
(CHX), ﬂuorides biguanide antiseptics, quaternary ammo-
nium-antiseptics and phenol derivatives [10, 11]. Although
these chemotherapeutic agents are eﬀective they can cause
side eﬀects, such as gastrointestinal irritation, tooth staining,
and gum irritation [11].
Dental treatment usually is expensive and not so eas-
ily accessible, especially in developing countries; therefore
humans have turned to the use of natural traditional reme-
dies to prevent oral ailments [12–15]. Artemisia afra (African
wormwood, family Asteraceae) is widely distributed along
the eastern parts of Africa. It grows in thick, bushy areas,2 Evidence-Based Complementary and Alternative Medicine
usually with tall stems up to 2m high but sometimes as low
as 0.6m. A. afra is a common species in South Africa with
a wide distribution from the Cederberg Mountains in the
Cape, northwards to tropical East Africa and stretching as far
north as Ethiopia [16, 17]. Worldwide there are about 500
species of Artemisia, mainly from the northern hemisphere.
Many of the other Artemisia species are aromatic perennials
and are used medicinally [18]. In southern Africa it is
used to treat coughs, colds, diabetes, malaria, sore throat,
asthma, headache, dental care, gout and intestinal worms
[19]. In vitro studies done have revealed that A. afra is a
potential antidepressant, cardiovascular, spasmolytic eﬀects,
antioxidant,andantimycobacteria[18,20,21].Furthermore,
the extracts of this plant species have shown activity against
Trypanosoma brucei brucei [22].
The rationale of this study was to determine the antimi-
crobial, antioxidant, and cytotoxicity of Artemisia afra and
isolated compounds against oral microorganisms which are
responsible for dental caries, gingivitis, and periodontitis.
2.MaterialsandMethods
2.1. Plant Material. Artemisia afra was collected at the South
African National Botanical Institute (SANBI), Pretoria.
Voucher specimen was prepared and identiﬁed at the H. G.
W. J. Schwelcherdt Herbarium (PRU), University of Pretoria.
2.2. Preparation of Extracts. Fresh plant material was soaked
in96%ethanolandhomogenizedintoﬁnemesh.Theextract
wasthenﬁlteredthroughtheWhatmanNo.1ﬁlterpaper.The
ﬁltrates were evaporated to dryness in a (BUCHI) Rotavapor
under reduced pressure of 40◦C.
2.3. Antimicrobial Assay
2.3.1. Microbial Strains. The microorganisms used in this
study include Actinomyces naeslundii (ATCC 19039), Actino-
myces israelii (ATCC 10049), Aggregatibacter actinomycetem-
comitans (ATCC 33384), Candida albicans (Med I), Por-
phyromonas gingivalis (ATCC 33277), Prevotella intermedia
(ATCC 25611), and Streptococcus mutans (ATCC 25175).
Bacteria were grown in the Casein-peptone Soy Agar me-
dium (CASO) (Merck SA (Pty) Ltd.) under anaerobic con-
ditions in a jar with anaerocult A (Merck SA (Pty) Ltd.), at
37◦C for 48 hours. Sabouraud Dextrose Agar medium (SDA)
(Merck SA (Pty) Ltd.) was used for the culturing of Candida
albicans and incubated at 37◦C for 24 hours under aerobic
conditions. Subculturing was done once weekly.
2.4. Determination of Minimum Inhibitory Concentration
(MIC) and Minimum Microbicidal Concentration (MMC).
The microdilution technique using 96-well microplates [23]
was used to obtain the MIC and MMC values of the crude
extract against microorganisms under study. The extract
was serially diluted in the 96-well plate with 48hours old
microorganisms (5 × 106 CFU/mL) grown at 37◦Ca n d
the ﬁnal concentration of extract and positive control
(CHX) ranged from 25.0mg/mL to 0.8mg/mL. Microbial
growth was indicated by adding 40μLo f( 0 . 2 m g / m L )p-
iodonitrotetrazolium violet (INT) (Sigma-Aldrich, South
Africa) to microplate wells and incubated at 37◦Cf o r4 8
hours. MIC was deﬁned as the lowest concentration that
inhibited the colour change of INT. The MMC was deter-
mined by adding 50μL of the suspensions from the wells,
which did not show any growth after incubation during
MIC assays, to 150μL of fresh broth. These suspensions were
reincubated at 37◦C for 48 hours. The MMC was determined
as the lowest concentration of extract which inhibited 100%
growth of microorganisms [24].
2.5. Antioxidant Activity. The free radical scavenging activity
was measured using 1, 1 diphenyl-2-picryl-hydraxyl (DPPH)
assay [25] with slight modiﬁcations. The ethanol extract
of A. afra and Vitamin C (positive control) 1000μg/mL
(20μL) was added in the ﬁrst three wells of a 96-well plate
containing 200μL of distilled water to make up ﬁnal
concentration of 100μg/mL and the remaining wells were
ﬁlled with 110μL of distilled water. The ﬁrst raws contain-
ing the extract/compounds were serially diluted to wells
which contain 110μL of distilled water, and later, 90μLo f
methanolic solution of DPPH (90mM) was added to all the
wells. The ﬁnal concentrations of the extract/compounds
ranged from 100 to 0.8μg/mL. The plates were incubated
at 37◦C for 30min and the absorbance was measured at
517nm using the ELISA plate reader. The percent radical
scavenging activity by A. afra was determined by comparison
with ethanol (blank). The inhibition ratio was calculated as
follows: % DPPH radical-scavenging = (AC-AS)/AC × 100,
where AC is absorbance of the control solution (containing
only DPPH solution), and AS is the absorbance of the
sample in DPPH solution. The percentage of DPPH radical-
scavenging was plotted against the plant extract/compounds
concentrations (μg/mL) to determine the concentration of
extract/compound required to scavenge DPPH by 50%
(EC50).
2.6. Determination of Cytotoxicity
2.6.1. Preparation of Extract and Compounds. Extract and
compounds were dissolved in dimethyl sulfoxide (DMSO)
a n ds t o r e da t−20◦C. All tested compounds were diluted to
the ﬁnal concentration with RPMI 1640 and control cultures
were diluted with 0.1% DMSO.
2.6.2. Cell Culture. McCoy cells were maintained in mono-
layer culture at 37◦C and 5% CO2 with 10% PBS Medium,
10μg/mL of penicillin, 10μg/mL, streptomycin, 40μg/mL
gentamycin, and 0.25μg/mL fungizone.
2.6.3. Cell ProliferationAssay. A microtiter plate with McCoy
cells was used for testing all the ethanol extracts for cytotoxi-
cityfollowingthemethodof[26].Cytotoxicitywasmeasured
by the XTT (sodium 3 -[1-(phenyl amino-carbonyl)-3,4-
tetrazolium]-bis-[4-methoxy-6-nitro] benzene sulfonic acid
hydrate) method using a cell proliferation kit II (Roche
Diagnostics GmbH). Hundred microlitres of McCoy cellsEvidence-Based Complementary and Alternative Medicine 3
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Figure 1: Chemical structures of compounds isolated from the aerial part of Artemisia afra.
(1 × 105 mL) was seeded onto a microtiter plate and incu-
bated for 24h to allow the cells to attach to the bottom of
the plate. Dilution series were made of the extract and com-
pound and the various concentrations (400 to 3.1μg/mL)
were added to the microtitre plate and incubated for 48h.
The XTT reagents were added to a ﬁnal concentration of
0.3mg/mL and the cells were incubated for 1-2 hours. The
positive drug control (Zearalenone) at concentrations range
of (10μg/mL to 0.6μg/mL) was included in the assay. After
incubation the absorbance of the colour was spectropho-
tometrically quantiﬁed using an ELISA plate reader, which
measured the optical density at 490nm with a reference
wavelengthof690nm.Theassaywascarriedoutintriplicate.
2.6.4. Statistical Analysis. Statistical analysis was conveyed as
means ± SD using GraphPad Prism 4.0 with a signiﬁcant
diﬀerence of (P<0.05).
3. Isolation andIdentiﬁcation of Compounds
The antibacterial compounds present in A. afra extract were
determined by the direct bioautography method of chro-
matograms using S. mutans [27]. The extract was spotted
onto a TLC plate and developed using hexane: ethyl acetate
at diﬀerent ratios (1:1, 3:7, and 7:3). The plates were
thoroughly dried and then the chromatograms were sprayed
with a dense culture of S. mutans, incubated overnight
at 37◦C. The plates were further sprayed with 0.2mg/mL
of p-iodonitrotetrazolium (INT) (Sigma). Clear zones of
inhibition indicated compounds which inhibited bacterial
growth. The isolation of compounds was performed using
column chromatography. Fractionation was preceded by
using silica gel 60 (70–230 mesh) and Sephadex LH 20. Thin
layer chromatography (TLC) was performed on aluminum
sheetscoatedwithsilicagel60F254 (Merck)andUVlightwas
used to detect compounds. TLC plates were further sprayed
withvanillin/sulphuricacidreagent.H1-NMRand 13C-NMR
spectra were obtained by using Nuclear magnetic resonance
(NMR) Germin 200 AT 199, 50Hz, respectively.
The Isolation of A. afra was started with 200g of ethanol
extract on to a 100mm diameter column. The column was
ﬁlled with 2kg silica gel, eluted with a mixture of hexane:
ethyl acetate of increasing polarity (100:0 to 0:100). Forty
fractions were obtained and combined to make up 12 (I-XII)
main fractions according to similarities of compounds as
determinedbyTLCplate.ASephadexcolumnwasconducted
on the fraction X using 100% MeOH and it yielded 25
subfractions which were combined in to three subfractions
(L, M, N). Fraction N was fractionated using MeOH and
yielded a pure compound 1. Fraction M was isolated using
a gradient of solvents DCM: Hex, 9:1 increasing polarity to
3% to obtain a ﬂorescent blue compound 3.4 Evidence-Based Complementary and Alternative Medicine
Table 1: Mean MIC and MMC (mg/mL) results of Artemisia afra on oral microorganisms.
Plant extracts
Microorganisms tested
MIC (μg/mL) MBC (μg/mL)
Gram +ve Gram –ve Yeast Gram +ve Gram –ve Yeast
A.n A.i A.a P.i P.g C.a A.n A.i A.a P.i P.g C.a
A. afra 3.1 1.6 25.0 6.3 6.3 6.3 1.6 6.3 >1.0 1.25 25.0 >25.0
1 1.0 0.25 >1.0 1.0 1.0 >1.0 1.0 0.5 >1.0 >1.0 >1.0 >1.0
2 0.5 0.5 >1.0 1.0 >1.0 >1.0 1.0 0.5 >1.0 1.0 >1.0 >1.0
3 1.0 0.25 >1.0 0.5 >1.0 >1.0 >1.0 0.5 >1.0 1.0 >1.0 >1.0
4 1.0 >1.0 >1.0 >1.0 >1.0 >1.0 >1.0 >1.0 >1.0 >1.0 >1.0 >1.0
5 >1.0 >1.0 >1.0 >1.0 >1.0 >1.0 >1.0 >1.0 >1.0 >1.0 >1.0 >1.0
6 0.25 1.0 >1.0 1.0 1.0 >1.0 0.5 1.0 >1.0 >1.0 >1.0 >1.0
Chlorhexidine 1.6 6.3 1.6 6.3 1.6 6.3 1.6 6.3 1.6 6.3 1.6 1.25
A.n: Actinomyces naeslundii; A.i: Actinomyces israelii;A . a :Actinobacillus actinomycetemcomitans; P.i: Prevotella intermedia;P . g :Porphyromonas gingivalis; C.a:
Candida albicans.
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Figure 2: The DPPH inhibitory activities of the isolated compounds and vitamin C.
Fraction VII was chromatographed using DCM: MeOH
(95:5), and 20 fractions were obtained and combined to
3 subfractions. Fraction G was fractionated using DCM:
MeOH, increasing polarity on a Sephadex column and
two fractions were obtained of which one was a pure
compound 2, the second fraction was again fractionated
using DCM: MeOH (95:5) and compound 6 was obtained.
Compound 5 was isolated using Hex: EtoAc, at a ratio of
9:1, using silica gel column. A succession of a blue-coloured
compound was observed on a TLC plate after application of
vanillin/sulphuric acid. Subfraction H from fraction VII was
chromatographed using a sephadex column with ethanol as
its mobile phase and it yielded a white precipitate of a pure
compound 4.
4. Results and Discussion
The TLC proﬁle gave a clear antibacterial activity of the
extract and guide to isolate ideal compounds. In all solvent
systems tested on TLC, both polar and nonpolar bends
demonstrated activity by inhibiting the growth of S. mutans.
Isolation from A. afra extract yielded six compounds
(Figure 1), one known ﬂavone Acacetin (1), sequiterpe-
ne12α,4α-dihydroxybishopsolicepolide (2), a diterpene Phy-
tol (5) [28, 29], and two pentacyclic triterpenes (4). A thor-
ough revision of literature indicated that the data for penta-
cyclic triterpene matched with those of α-Amyrin, a widely
spread triterpene in nature [30, 31]. The presence of the sig-
nalat3.0ofH-17conﬁrmsthestructureofBetulinicacid(6).Evidence-Based Complementary and Alternative Medicine 5
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Figure 3: The cytotoxicity eﬀects of A. afra extract and three selected compounds on the growth of the McCoy ﬁbroblast cells.
We have compound (3)ofwhichtheforgoingdataisidentical
with the known compound Scopoletin. All these compounds
were characterized by their 1H-NMR and 13C-NMR spectra.
The strong antimicrobial activity demonstrated by the
ethanolextractofA.afrahaspr o videduswithmor eevidenc e
that needed further chemical investigation of bioactive
compounds present. The extract of A. afra showed good
inhibitory eﬀects against all Gram positive bacteria. It can
be noted that the MIC and MMC values varied from
1.6 to 25.0mg/mL among Gram positive bacteria. C. albi-
cans which is a thick grower fungus was inhibited at a
concentration of 6.3mg/mL. However, the MMC value
insigniﬁcant as compared to the results of the MIC. The
A. actinomycetemcomitans was the resistant Gram negative
bacteria as compared to all other tested bacteria (Table 1).
The lowest MIC and MMC value of isolated compounds
was recorded at 0.25mg/mL of compounds (6), (3),a n d(1)
against A. israelii and A. naeslundii. Of all microorganisms,
A. actinomycetemcomitans and C. albicans showed to be
resistant against all compounds tested (Table 1).
The antioxidant activity of three selected compounds
(scopoletin, acacetin and betulinic acid) revealed that they
are eﬀective antioxidant agents (Figure 2). Scopoletin had a
strong transformation of the DPPH radical into its reduced
form, with an IC50 value of 1.24μg/mL which was in close
range to that of vitamin C (1.22μg/mL). Acacetin and Betul-
inic acid exhibited a slightly low DPPH scavenging activity
with the IC50 of 2.39 and 2.42μg/mL, respectively.
Thecytotoxicity eﬀectsof ethanol crudeextractof A.afra
and three selected compound on the growth of Fibroblast
cells are shown in Figure 3 and Table 2.T h ee x t r a c ta sa
Table 2: The IC50 values of crude extract and three selected isolated
compounds.
Extract/compounds IC50(μg/mL) STD
Betulinic Acid 30.96 ±1.95
Acacetin 35.44 ±2.14
Scopoletin 132.5 ±1.85
Artemisia afra 16.95 ±1.82
Actinomycin-D 0.003364 ±0.00002
mixture of diﬀerent components showed to be nontoxic on
lower concentrations of 6.12 and 3.06μg/mL, with the cell
viability of 120%. However, toxic eﬀects were apparent at
higher concentration range of 12.50 to 400μg/mL, with
the cell viability of 60 to 20%. Acacetin and betulinic
acid also showed a smooth trend of nontoxic eﬀects at
lower concentrations and toxic at higher concentrations
with IC50 values of 35.44 and 30.96μg/mL respectively. The
eﬀect of acacetin on lung cancer (A549) cell proliferation
was observed to have a dose-dependent manner with an
IC50 value of 9.46μM[ 32]. Apoptotic activity of betulinic
acid against murine melanoma B16 cell line was reported
and it was discovered that betulinic acid induces apoptotic
eﬀects with an IC50 of 22.5μg/mL [33]. Reports postulates
that triterpenes with a carboxyl group at c-28 shows more
cytotoxicactivityagainstcancercelllines[34–36]andinduce
apoptosis [37]. Unexpectedly, one out of three compounds
tested, scopoletin was relatively nontoxic with an IC50 value
of 132.5μg/mL.6 Evidence-Based Complementary and Alternative Medicine
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